Michael LaSala, PhD, LCSW, Rutgers School of Social Work provides patients with top tips for steps to mitigate the specific mental health side effects of anal cancer treatment.

It took about nine weeks to make the vaccine but the company expects the process could be shortened to four weeks.

1/4/2021. Presentation by Rachel Kludy (pl251291@ahschool.com)

Pancreas| Function of Pancreas | Class 10 Biology
#pancreas #pancreatic #endocrinegland

In this video you will learn about Pancreas. Pancreas is the organ which perform both exocrine and endocrine activity. In exocrine activity it is helpful in digestive system. It releases Pancreatic juice which helps in the digestion of food. But in endocrine activity it releases two hormones
Insulin and Glucagon.
Insulin decreases the blood glucose level and Glucagon increases the blood glucose level.

Your Queries.
What is pancreas
What is the location of pancreas
Pancreas
Pancreas Class 10
What is the function of pancreas
Function of Pancreas
Function of Pancreas class 10
Pancreatic juice
Insulin
glucagon
Function of pancreatic juice
Function of insulin
Function of glucagon

#pancreas #pancreatic #pancretic_stone #pancreatic_tumor #endocrinegland #exocrine #gland #insulin #glucose #glucagon #digestion #digestivejuices #endocrinology #exocrinology #function#pancreaticcancer #functuonofinsulin #structure #pancrease
#pancreatitis #biology #easybiology #class10biology #10class #10th #10classbiology

Patient and caregiver symposium held in Pittsburgh at UPMC in which leading melanoma expert, Dr. John Kirkwood discusses emerging therapies, the importance of clinical trials, and innovations in research.

This webinar is part of the 2014 online learning series 'What you need to know about brain tumours'

This free webinar will be of particular interest to pediatric-focused health care professionals, as well as family members and survivors of medulloblastoma.

In this webinar you will learn about how a medulloblastoma brain tumour is treated in children and whether these principles can apply to adults. Following this overview, there will be a review of the recent molecular classification of this most common malignant pediatric brain tumour and why these discoveries provide a framework to devise new treatment protocols.

By participating in this webinar you will learn:
- Understanding of the multidisciplinary treatment of medulloblastoma
- Comparisons of pediatric and adult medulloblastoma
- Understanding of the new molecular sub-classification and its application to new treatments

This webinar was presented on Wednesday, March 19, 2014; 12:00 pm - 1:00 pm EST by Dr. David Eisenstat, Professor and Division Director, Hematology / Oncology & Palliative Care
University of Alberta (Edmonton, AB)

#PushingGlassCoast2Coast #TheModernPathologist #PathologyIsLife

Although rare, they need to be differentiated from lung cancer or lung metastasis. its is imperative then to have a knowledge of their presence and management.

This channel aim at providing chest medicine and surgery review of literature and personal experience more than 25 years of practice. its an enrichment ebook. The objective is to provide a condense and consice reviews for each subject in 10 minutes to provide the audience (medical students and post graduates as well as professional surgeons) with updated science.
If you have any question to discuss do not hesitate to share.
All comments to improve the channel is welcomed.

Pleuropulmonary Blastoma is a malignant pediatric lung cancer that is highly aggressive and very rare. It carries a poor prognosis Here we have a 3 year old male patient with a history of persistent cough.

There a 4 types of PBB
Type I - mainly cystic with malignant cells
Type Ir - cystic without evidence for malignancy
Type III - Cystic with nodules
Type IV - Solid

Imaging included:
Ultrasound
CT
PET

Don't forget to follow Sonographic Tendencies on facebook


Thank you
Henry Suarez RDMS, RVT

SRT 100 Vision ( Supeficial RadioTherapy ) is the non invasive treatment option for non melanoma skin cancer and keloid scars.

Martine Bagot, MD, PhD, Hôpital Saint Louis, Paris, France, presents results from post hoc analyses of the MAVORIC trial (NCT01728805), a Phase III study evaluating mogamulizumab versus vorinostat in patients with previously treated cutaneous T-cell lymphoma (CTCL). Follow-up studies indicated that long-term responses were not associated with new side effects. In addition, a subset of patients is still in partial or complete response after long-term treatment with mogamulizumab. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.